S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
MarketBeat Week in Review – 3/20 - 3/24
Germany, EU reach agreement in combustion engine row
The gold catalyst we’ve waited for (Ad)
Bank failures and rescue test Yellen's decades of experience
Intel co-founder, philanthropist Gordon Moore dies at 94
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
'What can we do?': Millions in African countries need power
ConocoPhillips details gas leak cause, remedies at hearing
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
MarketBeat Week in Review – 3/20 - 3/24
Germany, EU reach agreement in combustion engine row
The gold catalyst we’ve waited for (Ad)
Bank failures and rescue test Yellen's decades of experience
Intel co-founder, philanthropist Gordon Moore dies at 94
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
'What can we do?': Millions in African countries need power
ConocoPhillips details gas leak cause, remedies at hearing
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
MarketBeat Week in Review – 3/20 - 3/24
Germany, EU reach agreement in combustion engine row
The gold catalyst we’ve waited for (Ad)
Bank failures and rescue test Yellen's decades of experience
Intel co-founder, philanthropist Gordon Moore dies at 94
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
'What can we do?': Millions in African countries need power
ConocoPhillips details gas leak cause, remedies at hearing
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
MarketBeat Week in Review – 3/20 - 3/24
Germany, EU reach agreement in combustion engine row
The gold catalyst we’ve waited for (Ad)
Bank failures and rescue test Yellen's decades of experience
Intel co-founder, philanthropist Gordon Moore dies at 94
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
'What can we do?': Millions in African countries need power
ConocoPhillips details gas leak cause, remedies at hearing
NASDAQ:BMRA

Biomerica - BMRA Stock Forecast, Price & News

$1.98
+0.06 (+3.13%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.87
$1.99
50-Day Range
$1.86
$3.00
52-Week Range
$1.84
$5.25
Volume
7,823 shs
Average Volume
57,045 shs
Market Capitalization
$33.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BMRA stock logo

About Biomerica (NASDAQ:BMRA) Stock

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The firm focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other. The company was founded in September 1971 and is headquartered in Irvine, CA.

Receive BMRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biomerica and its competitors with MarketBeat's FREE daily newsletter.

BMRA Stock News Headlines

Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
See More Headlines
Receive BMRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biomerica and its competitors with MarketBeat's FREE daily newsletter.

BMRA Company Calendar

Last Earnings
1/13/2023
Today
3/25/2023
Next Earnings (Estimated)
4/13/2023
Fiscal Year End
5/31/2023

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BMRA
Employees
66
Year Founded
1971

Profitability

Net Income
$-4,530,000.00
Pretax Margin
-34.48%

Debt

Sales & Book Value

Annual Sales
$18.87 million
Book Value
$0.65 per share

Miscellaneous

Free Float
14,173,000
Market Cap
$33.28 million
Optionable
Not Optionable
Beta
-0.53

Social Links


Key Executives

  • Zackary S. Irani
    Chairman & Chief Executive Officer
  • Gary Lu
    Chief Financial & Accounting Officer
  • Robert Carlson
    Chief Commercial Officer













BMRA Stock - Frequently Asked Questions

How have BMRA shares performed in 2023?

Biomerica's stock was trading at $3.35 at the beginning of 2023. Since then, BMRA stock has decreased by 40.9% and is now trading at $1.98.
View the best growth stocks for 2023 here
.

When is Biomerica's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 13th 2023.
View our BMRA earnings forecast
.

How were Biomerica's earnings last quarter?

Biomerica, Inc. (NASDAQ:BMRA) announced its quarterly earnings results on Friday, January, 13th. The company reported ($0.12) earnings per share (EPS) for the quarter. The company had revenue of $1.48 million for the quarter. Biomerica had a negative net margin of 34.58% and a negative trailing twelve-month return on equity of 66.11%.

What other stocks do shareholders of Biomerica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biomerica investors own include Sorrento Therapeutics (SRNE), Pfizer (PFE), Johnson & Johnson (JNJ), Ampio Pharmaceuticals (AMPE), OPKO Health (OPK), TG Therapeutics (TGTX), Advanced Micro Devices (AMD), Co-Diagnostics (CODX), FuelCell Energy (FCEL) and Trevena (TRVN).

What is Biomerica's stock symbol?

Biomerica trades on the NASDAQ under the ticker symbol "BMRA."

Who are Biomerica's major shareholders?

Biomerica's stock is owned by a number of institutional and retail investors. Top institutional investors include Point72 Asset Management L.P. (3.12%), Geode Capital Management LLC (0.67%), Russell Investments Group Ltd. (0.47%), Hollencrest Capital Management (0.37%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Allen Barbieri, Catherine Coste, Mark A Sirgo and Zackary S Irani.
View institutional ownership trends
.

How do I buy shares of Biomerica?

Shares of BMRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Biomerica's stock price today?

One share of BMRA stock can currently be purchased for approximately $1.98.

How much money does Biomerica make?

Biomerica (NASDAQ:BMRA) has a market capitalization of $33.28 million and generates $18.87 million in revenue each year. The company earns $-4,530,000.00 in net income (profit) each year or ($0.43) on an earnings per share basis.

How can I contact Biomerica?

Biomerica's mailing address is 17571 Von Karman Avenue, Irvine CA, 92614. The official website for the company is www.biomerica.com. The company can be reached via phone at (949) 645-2111, via email at jnesbett@institutionalms.com, or via fax at 949-553-1231.

This page (NASDAQ:BMRA) was last updated on 3/25/2023 by MarketBeat.com Staff